Thank you for attending the 3rd Brain Innovation Days Digital Session, Fast-tracking brain innovation in times of COVID-19 last Tuesday! We hope you enjoyed the event as much as we did and found the discussion and insight from our speakers relevant and interesting, looking at COVID-19 from a different angle and discovering potential lessons-learned to be[…]
We are very proud to announce our new partnership with Imec! Imec aims to be the world’s best center for R&D and innovation in nanoelectronics and digital technologies. They partner with many companies, start-ups and universities to bring together brilliant minds in a creative and stimulating environment. Imec accelerates progress towards a connected and sustainable future through their world-class infrastructure and local and global[…]
Imcyse raises €21M and opens its capital to its new American partner, Pfizer. Very good news for the Liège-based biotech company Imcyse. Indeed, the biotech has developed an active immunotherapy technology that allows to tackle autoimmune diseases such as multiple sclerosis, type 1 diabetes or rheumatoid arthritis. A licensing agreement has just been signed with[…]
Registration is now open for the upcoming Brain Innovation Days Digital Session, Fast-tracking brain innovation in times of COVID-19, which we are co-organising with the European Brain Council on 27 April at 12:30-14:00. REGISTER NOW The last 14 months have been testing for global health. COVID-19 exposed weaknesses in public health systems’ preparedness to face pandemics and we continue to face[…]